Defining differentially methylated regions specific for the acquisition of pluripotency and maintenance in human pluripotent stem cells via microarray

PLoS One. 2014 Sep 24;9(9):e108350. doi: 10.1371/journal.pone.0108350. eCollection 2014.

Abstract

Background: Epigenetic regulation is critical for the maintenance of human pluripotent stem cells. It has been shown that pluripotent stem cells, such as embryonic stem cells and induced pluripotent stem cells, appear to have a hypermethylated status compared with differentiated cells. However, the epigenetic differences in genes that maintain stemness and regulate reprogramming between embryonic stem cells and induced pluripotent stem cells remain unclear. Additionally, differential methylation patterns of induced pluripotent stem cells generated using diverse methods require further study.

Methodology: Here, we determined the DNA methylation profiles of 10 human cell lines, including 2 ESC lines, 4 virally derived iPSC lines, 2 episomally derived iPSC lines, and the 2 parental cell lines from which the iPSCs were derived using Illumina's Infinium HumanMethylation450 BeadChip. The iPSCs exhibited a hypermethylation status similar to that of ESCs but with distinct differences from the parental cells. Genes with a common methylation pattern between iPSCs and ESCs were classified as critical factors for stemness, whereas differences between iPSCs and ESCs suggested that iPSCs partly retained the parental characteristics and gained de novo methylation aberrances during cellular reprogramming. No significant differences were identified between virally and episomally derived iPSCs. This study determined in detail the de novo differential methylation signatures of particular stem cell lines.

Conclusions: This study describes the DNA methylation profiles of human iPSCs generated using both viral and episomal methods, the corresponding somatic cells, and hESCs. Series of ss-DMRs and ES-iPS-DMRs were defined with high resolution. Knowledge of this type of epigenetic information could be used as a signature for stemness and self-renewal and provides a potential method for selecting optimal pluripotent stem cells for human regenerative medicine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amniotic Fluid / cytology
  • Cell Line
  • Cellular Reprogramming
  • DNA Methylation*
  • Epigenesis, Genetic
  • Female
  • Gene Expression Profiling / methods*
  • Genome, Human
  • Humans
  • Pluripotent Stem Cells / physiology*
  • Pregnancy
  • Tissue Array Analysis / methods*

Associated data

  • GEO/GSM1399275
  • GEO/GSM1399276
  • GEO/GSM1399277
  • GEO/GSM1399278
  • GEO/GSM1399279
  • GEO/GSM1399280
  • GEO/GSM1399281
  • GEO/GSM1399282
  • GEO/GSM1399283
  • GEO/GSM1399284

Grants and funding

This work was supported in part by grants from the Ministry of Science and Technology of China Grants (973 program; 2014CB943203), Ph.D. Programs Foundation of Ministry of Education of China (20110001120008), the National Natural Science Foundation of China (81100473, 81100404, 81370766, U1132005), Guangdong Natural Science Funds (S2013010014781), the Zhujiang Science and Technology Star Project of Guangzhou (2012J2200006) and Guangdong Province Higher Education Funding (2013KJCX0149, Yq2013135). Union Stem Cell & Gene Engineering Co., Ltd. provided support in the form of a salary for author ZYL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the ‘author contributions’ section.